Aprotinin interacts with substrate-binding site of human dipeptidyl peptidase III.


Journal

Journal of biomolecular structure & dynamics
ISSN: 1538-0254
Titre abrégé: J Biomol Struct Dyn
Pays: England
ID NLM: 8404176

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 11 9 2018
medline: 9 7 2020
entrez: 11 9 2018
Statut: ppublish

Résumé

Human dipeptidyl peptidase III (hDPP III) is a zinc-exopeptidase of the family M49 involved in final steps of intracellular protein degradation and in cytoprotective pathway Keap1-Nrf2. Biochemical and structural properties of this enzyme have been extensively investigated, but the knowledge on its contacts with other proteins is scarce. Previously, polypeptide aprotinin was shown to be a competitive inhibitor of hDPP III hydrolytic activity. In this study, aprotinin was first investigated as a potential substrate of hDPP III, but no degradation products were demonstrated by MALDI-TOF mass spectrometry. Subsequently, molecular details of the protein-protein interaction between aprotinin and hDPP III were studied by molecular modeling. Docking and long molecular dynamics (MD) simulations have shown that aprotinin interacts by its canonical binding epitope with the substrate binding cleft of hDPP III. Thereby, free N-terminus of aprotinin is distant from the active-site zinc. Enzyme-inhibitor complex is stabilized by intermolecular hydrogen bonding network, electrostatic and hydrophobic interactions which mostly involve constituent amino acid residues of the hDPP III substrate binding subsites S1, S1', S2, S2' and S3'. This is the first study that gives insight into aprotinin binding to a metallopeptidase. Communicated by Ramaswamy H. Sarma.

Identifiants

pubmed: 30198396
doi: 10.1080/07391102.2018.1521343
doi:

Substances chimiques

Amino Acids 0
Solvents 0
Aprotinin 9087-70-1
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases EC 3.4.14.-
dipeptidyl peptidase III EC 3.4.14.4
Zinc J41CSQ7QDS

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3596-3606

Auteurs

Dejan Agić (D)

a Department of Chemistry, Faculty of Agriculture in Osijek , Josip Juraj Strossmayer University of Osijek , Osijek , Croatia.

Hrvoje Brkić (H)

b Department of Biophysics and Radiology, Faculty of Medicine , Josip Juraj Strossmayer University of Osijek , Osijek , Croatia.
c Department of Biophysics and Radiology, Faculty of Dental Medicine and Health , Josip Juraj Strossmayer University of Osijek , Osijek , Croatia.

Saša Kazazić (S)

d Division of Physical Chemistry , Ruđer Bošković Institute , Zagreb , Croatia.

Antonija Tomić (A)

e Division of Organic Chemistry and Biochemistry , Ruđer Bošković Institute , Zagreb , Croatia.

Marija Abramić (M)

e Division of Organic Chemistry and Biochemistry , Ruđer Bošković Institute , Zagreb , Croatia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH